FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES. CMN. 2024;6(2):7092-7101. Accessed August 3, 2026. https://cahiersmagellanes.com/index.php/CMN/article/view/1040